Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Getting an Accurate Read on Parkinson's

30.06.2011
New algorithm reveals twice as many sufferers as previously estimated, says TAU researcher

Parkinson's Disease, brought to public awareness by figures such as Michael J. Fox, is not just difficult to diagnose. It's also difficult to accurately estimate how many people actually suffer from the disease. Current statistics come from small-scale studies, usually based on information from hospital clinics, and no registries or formal databases exist to track how many people have the disease.

Dr. Chava Peretz of Tel Aviv University's School of Public Health at the Sackler Faculty of Medicine, Ph.D. student Orly Chillag-Talmor from Haifa University and researchers from Tel Aviv Sourasky Medical Center and Maccabi Healthcare Services have devised a unique algorithm to more precisely determine the size of a population that suffers from the disease. This will permit researchers to better prepare for the consequences to public health, and provide more realistic estimates on how much it will cost to treat this growing number of patients.

The researchers have developed a refined drug-tracer algorithm. Based upon a patient's medication history, it assigns them to one of three potential categories of Parkinson's sufferers: those who definitely have the disease, those who probably have it, and those who only possibly have it. The algorithm identifies patients in each of these categories with 95 percent accuracy. The results of the research recently appeared in the Journal of Parkinson's Disease.

Sifting through a decade of prescriptions

It has been estimated that one percent of the population over the age of 60 suffers from Parkinson's, but Dr. Peretz questioned this estimate, believing that the numbers might be far greater.

Their algorithm is based on four factors: the kind of anti-Parkinson drug prescribed; the age at which the patient was first entered into the system; the length of the follow-up period; and the number and continuity of drug purchases. They then compared her results to the database of purchased pharmaceuticals from Israel's second largest HMO, Maccabi Health Care. This database comprises ten years' worth of prescriptions, representing about 25 percent of the population.

Researchers were searching for both prevalent cases (the number of people currently living with Parkinson's) and incident cases (the number of people each year newly diagnosed with the disease). "Based on this algorithm," Dr. Peretz explains, "we identified about 7,000 Parkinson's disease prevalent cases and about 5,000 incident cases in the study period."

These results, notes Dr. Peretz, represented a departure from previously accepted statistics and confirmed her suspicions. The team determined that the prevalence rate for the population was one percent for patients over 50 years of age, two percent for those over 60, and three percent for ages 70 and above — twice the previous estimation. In addition, the mean age at time of first diagnosis was found to be around 70 years, rather than 60 years.

To confirm the results, Dr. Peretz and her fellow researchers carried out a validity test with Maccabi patients at the Tel Aviv Sourasky Medical Center's Movement Disorder Clinic. The algorithm managed to accurately identify 95 percent of the patients, she says.

A warning for public health professionals

Dr. Peretz points to misdiagnoses as one of the causes of poor information on Parkinson's. Not only is the prevalence rate of Parkinson's higher than previously thought, but the rate is growing by six percent yearly. There are on average 33 new cases for every 100,000 people per year. This spells trouble for governmental public health agencies, which will shoulder a heavier burden than they expected in the coming years. "It's a disease that costs a lot, the expectation of life is growing, and we have to prepare," warns Dr. Peretz. "Public health institutions have a responsibility to be aware that these needs will arise."

However, these results also bring good news for those who research the causes of the disease. With more accurate statistics, explains Dr. Peretz, other researchers can explore various determinates of the disease and possible risk factors, such as those related to environmental exposure, occupation and lifestyle.

This work was partly supported by the Environment and Health Fund, Jerusalem, Israel.

George Hunka | EurekAlert!
Further information:
http://www.aftau.org

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

Bare bones: Making bones transparent

27.04.2017 | Life Sciences

Study offers new theoretical approach to describing non-equilibrium phase transitions

27.04.2017 | Physics and Astronomy

From volcano's slope, NASA instrument looks sky high and to the future

27.04.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>